BREAKING
CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 41 minutes ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 13 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 16 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 18 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 22 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 24 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 1 day ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 41 minutes ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 13 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 16 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 18 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 22 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 24 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 1 day ago
ADVERTISEMENT
AlphaGraphs

PFE Earnings: Key quarterly highlights from Pfizer’s Q4 2023 financial results

Pfizer Inc. (NYSE: PFE) reported fourth quarter 2023 earnings results today. Revenues declined 41% year-over-year to $14.2 billion, missing estimates. The company reported a net loss of $3.37 billion, or $0.60 per share, compared to a net income of $4.9 billion, or $0.87 per share, last year. Adjusted EPS decreased 91% to $0.10 but beat […]

January 30, 2024 1 min read

Pfizer Inc. (NYSE: PFE) reported fourth quarter 2023 earnings results today.

Revenues declined 41% year-over-year to $14.2 billion, missing estimates.

The company reported a net loss of $3.37 billion, or $0.60 per share, compared to a net income of $4.9 billion, or $0.87 per share, last year. Adjusted EPS decreased 91% to $0.10 but beat expectations.

Pfizer expects revenues of $58.5-61.5 billion for the full year of 2024. Adjusted EPS is expected to be $2.05-2.25.

The stock stayed in green during premarket hours on Tuesday.

ADVERTISEMENT

Prior performance

ADVERTISEMENT